Status:
ACTIVE_NOT_RECRUITING
Myopic Optic Neuropathy in Chinese High Myopia Population
Lead Sponsor:
Sun Yat-sen University
Conditions:
Eye Diseases
Eligibility:
All Genders
18+ years
Brief Summary
This study intends to establish a registry cohort to enroll patients with high myopia to study the natural course of myopic optic neuropathy in Chinese adult population.
Detailed Description
Global prevalence of high myopia brings about markedly increasing of blinding complications as myopic optic neuropathy (MON) and glaucoma. It was estimated that there were 163 million people who have ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Age ≥18 years
- Equivalent spherical ≤-6D or axial length ≥26.5mm
- Best corrected visual acuity ≥ 6/12
- Exclusion Criteria
- Unwilling or unable to give consent, or unable to return for scheduled protocol visits.
- Glaucoma secondary to penetrating keratoplasty, trauma, steroids, retinal disease/surgery, or neovascular disease.
- Obvious corneal and iris lesions, or severe cataracts interfering with fundus examinations, VF test or monophthalmia.
- Need for ocular surgery/laser or anticipated need for cataract surgery during the study period.
- Other serious systemic diseasesf (i.e. hypertension, heart disease, diabetes, or rheumatic immune system diseases);
- Pregnant or nursing women
Exclusion
Key Trial Info
Start Date :
June 6 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
813 Patients enrolled
Trial Details
Trial ID
NCT04302220
Start Date
June 6 2019
End Date
June 30 2026
Last Update
December 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Ophthalmic Center
Guangzhou, Guangdong, China, 510000